L A Kiemeney
Overview
Explore the profile of L A Kiemeney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
2071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ripping T, Rammant E, Witjes J, Aaronson N, Van Hemelrijck M, van Hoogstraten L, et al.
Health Qual Life Outcomes
. 2022 Dec;
20(1):171.
PMID: 36581934
Background: Quality of Life (QoL) of bladder cancer patients has been largely neglected. This is partly due to the lack of well-validated QoL questionnaires. The aim of this study is...
2.
Creemers S, Van Santvoort B, van den Berkmortel F, Kiemeney L, van Oort I, Aben K, et al.
Prostate Cancer Prostatic Dis
. 2022 Jul;
26(1):133-141.
PMID: 35798856
Background: The recommended treatment for a subset of patients with metastatic prostate cancer (mPC) changed from androgen deprivation therapy (ADT) to combinations with chemotherapy such as docetaxel. Implementation of new...
3.
Vernooij R, Cremers R, Jansen H, Somford D, Kiemeney L, van Andel G, et al.
Urol Oncol
. 2022 Jun;
40(7):353.
PMID: 35654644
No abstract available.
4.
van Santvoort B, van Leenders G, Kiemeney L, van Oort I, Wieringa S, Jansen H, et al.
Scand J Urol
. 2020 Aug;
54(6):463-469.
PMID: 32845207
Background: Grading prostate biopsies has an important role in determining treatment strategy. Histopathological evaluations suffer from interobserver variability and therefore biopsies may be re-evaluated. Objective: To provide insight into the...
5.
Vernooij R, Cremers R, Jansen H, Somford D, Kiemeney L, van Andel G, et al.
Urol Oncol
. 2020 Jul;
38(9):735.e17-735.e25.
PMID: 32680820
Background: Although urinary adverse events after treatment of prostate cancer (CaP) are common, population-based studies on functional outcomes are scarce. The aim of this study is to evaluate the occurrence...
6.
Ripping T, Kiemeney L, van Hoogstraten L, Witjes J, Aben K
BMC Cancer
. 2020 May;
20(1):455.
PMID: 32434491
Background: Despite the embedding of bladder cancer management in European guidelines, large variation in clinical practice exists for applied diagnostics and treatments. This variation may affect patients' outcomes including complications,...
7.
Arias-Vasquez A, Groffen A, Spijker S, Ouwens K, Klein M, Vojinovic D, et al.
Behav Genet
. 2019 Jan;
49(3):270-285.
PMID: 30659475
We aimed to detect Attention-deficit/hyperactivity (ADHD) risk-conferring genes in adults. In children, ADHD is characterized by age-inappropriate levels of inattention and/or hyperactivity-impulsivity and may persists into adulthood. Childhood and adulthood...
8.
Bralten J, van Hulzen K, Martens M, Galesloot T, Arias Vasquez A, Kiemeney L, et al.
Mol Psychiatry
. 2017 Jun;
PMID: 28630455
This corrects the article DOI: 10.1038/mp.2017.98.
9.
Diekstra M, Fritsch A, Kanefendt F, Swen J, Moes D, Sorgel F, et al.
CPT Pharmacometrics Syst Pharmacol
. 2017 Jun;
6(9):604-613.
PMID: 28571114
The tyrosine kinase inhibitor sunitinib is used as first-line therapy in patients with metastasized renal cell carcinoma (mRCC), given in fixed-dose regimens despite its high variability in pharmacokinetics (PKs). Interindividual...
10.
Bralten J, van Hulzen K, Martens M, Galesloot T, Arias Vasquez A, Kiemeney L, et al.
Mol Psychiatry
. 2017 May;
23(5):1205-1212.
PMID: 28507316
Autism spectrum disorders (ASDs) and autistic traits in the general population may share genetic susceptibility factors. In this study, we investigated such potential overlap based on common genetic variants. We...